4C Medical Technologies, Inc.

9 articles about 4C Medical Technologies, Inc.

• 4C Medical Technologies Presents Data from the Global Clinical Experience for the AltaValve Early Feasibility Study at AATS 2022

  5/19/2022

  4C Medical Technologies, Inc. presented its global clinical experience from its initial AltaValve Early Feasibility Study cases at the American Association for Thoracic Surgery 2022 Mitral Conclave Workshop on May 13, 2022 in Boston, MA.

• 4C Medical Technologies Announces Completion of a $10 Million Over-Subscribed Convertible Note Financing

  12/22/2020

  4C Medical Technologies, Inc. (4C Medical), a privately-held medical technology company focused on the development of minimally invasive technologies for structural heart disease, today announced it has completed an over-subscribed convertible note financing in which it has raised $10 million in gross proceeds.

• AltaValve™, 4C Medical's Novel Transcatheter Mitral Regurgitation Device Highlighted at TCT 2019

  9/30/2019

  4C Medical Technologies, Inc., the creator of a new generation of therapies for structural heart disease, announced that its medical device therapy for mitral regurgitation, AltaValve™, was featured at Transcatheter Cardiovascular Therapeutics 2019, on Sept 25-29 in San Francisco, CA.

• 4C Medical Group to adopt Elation Health's Clinical Engagement Platform

  10/25/2018

  Phoenix area integrated medical group will implement Elation's Clinical First electronic health record to drive physician engagement, operational efficiency & patient outcomes

• 4C Medical's AltaValve First In Human Experience to be Presented at TCT 2018

  9/13/2018

  4C Medical Technologies, Inc. today announced that its AltaValve™, a transcatheter mitral valve replacement (TMVR) technology, will be highlighted in the following presentations at the Transcatheter Cardiovascular Therapeutics (TCT) meeting held September 21-25, 2018 in San Diego, CA

• 4C Medical's Novel Transcatheter Mitral Valve Presented at TCT 2017 Shark Tank Innovation Competition

  11/2/2017

  The device was one of the eight innovations selected among nearly fifty submissions.

• 4C Medical Tech's Novel Mitral Regurgitation Therapy Highlighted At CVI 2017 Innovation Summit

  8/3/2017

• 4C Medical Tech Exceeds $8 Million Convertible Note Financing Round Led By Anges Québec

  7/19/2017

• 4C Medical Tech's Novel Mitral Regurgitation Therapy Highlighted At TVT Innovation Forum

  6/15/2017